PHYTOSPAGYRIE N°9 SYNDROME PRÉMENSTRUEL MÉNOPAUSE
Food supplement declared in France, declaration No 2018-10-571
PHYTOSPAGYRIE N°9 SYNDROME PRÉMENSTRUEL MÉNOPAUSE (HERBIER DU VELAY) is a food supplement declared in France. Status: withdrawn from the market on 19 January 2023. Main ingredients: Vaccinium vitis-idaea 375 mg per day, Alchemilla vulgaris 375 mg per day, Artemisia vulgaris 375 mg per day, Rubus idaeus 375 mg per day. 2 rules of use apply to its ingredients (limits and warnings).
- Brand
- HERBIER DU VELAY
- Food business operator placing the product on the market
- SAS VECTEUR ENERGY
- Status
- Withdrawn from the market on 19 January 2023
- Form
- Bottle
- Daily dose
- 10
- Directions for use
- Prendre 5 ml (1 cuillère à café) matin et soir, à diluer dans 5 à 10 volumes d'eau. Agiter avant uti
- Intended populations
- Women
- Not recommended (according to the manufacturer)
- Breastfeeding women, Pregnant women
- Objectives stated by the manufacturer (these are not authorised claims)
- Menstrual cycles, Menopause
Declaration 159029, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Vaccinium vitis-idaea L. | Feuille | Macérât hydroglycériné | 375 mg |
| Alchemilla vulgaris L. | Parties aériennes | Macérât hydroglycériné | 375 mg |
| Artemisia vulgaris L. | Parties aériennes | Macérât hydroglycériné | 375 mg |
| Rubus idaeus L. | Feuille | Macérât hydroglycériné | 375 mg |
Additives
E422
Other ingredients
Vitis vinifera L.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Label warnings
Le Framboisier et l'Airelle sont déconseillés chez les femmes enceintes et allaitantes.
Regulatory points
- Conditions légales
Vaccinium vitis-idaea L.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux femmes enceintes.
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
- Conditions légales
Artemisia vulgaris L.: L'huile essentielle de cette plante est interdite.
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
- Information
Withdrawn from the market on 19 January 2023, according to Compl'Alim.
Source: Compl'Alim, food supplement declarations (France).
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Artemisia vulgaris L.
Read the warning, when it applies and the studies cited
MUGWORT - ARTEMISIA VULGARIS
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Contraindications
Do not use if you are pregnant or breastfeeding (Brinker 2010; Blumenthal et al. 1998; Williamson et al. 1988).
Sources cited by Health Canada (3)
- Blumenthal M, Busse W, Goldberg A, Gruenwald J, Hall T, Riggins C, Rister R, editors. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. Austin (TX): American Botanical Council; 1998.
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Williamson EM, Evans FJ, Wren RC. Potter's New Cyclopaedia of Botanical Drugs and Preparations. Saffron Walden (UK): C.W. Daniel Company Limited; 1988.
Known adverse reactions
Stop use if hypersensitivity/allergy occurs (Brinker 2010; Wichtl 2004; Hoffmann 2003).
Sources cited by Health Canada (3)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Hoffmann D. Medical Herbalism. Rochester (VT): Healing Arts Press; 2003.
- Wichtl M, editor. Herbal Drugs and Phytopharmaceuticals: A Handbook for Practice on a Scientific Basis, 3rd edition. Stuttgart (D): Medpharm GmbH Scientific Publishers; 2004.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Brand : HERBIER DU VELAY
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “PHYTOSPAGYRIE N°9 SYNDROME PRÉMENSTRUEL MÉNOPAUSE (HERBIER DU VELAY): composition and regulation”, https://compoatlas.com/en/supplements/products/159029-phytospagyrie-n-9-syndrome-premenstruel-menopause, updated 15 November 2026.